The SAVE Trial: Securing All intraVenous devices Effectively in hospitals. A randomised controlled trial
The SAVE Trial: Securing All intraVenous devices Effectively in hospitals. A randomised controlled trial
批准号:
nhmrc : 1041910
负责人:
A/Pr E Geoffrey Playford
金额:
$65.37万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2017-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Going to hospital usually means having an IV drip in your hand or arm vein. Almost half of all IV drips fall out or fail because they are not well secured to the skin. This means patients miss out on treatment and have additional painful needlesticks to insert new devices. Serious infections can also occur. This study will find the best dressings to use on IV drips. Patients will have their drips glued in with medical superglue, or have one of two new dressings, compared with current usual care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
What makes sunspots become invasive cancers
-
批准号:nhmrc : GNT1059012
-
项目类别:Project Grants
-
资助金额:$113.0万
-
财政年份:2014
-
负责人:A/Pr E Geoffrey Playford
-
依托单位:
Determinants of progression of actinic keratoses to squamous cancer
-
批准号:nhmrc : 1059012
-
项目类别:Project Grants
-
资助金额:$79.25万
-
财政年份:2014
-
负责人:A/Pr E Geoffrey Playford
-
依托单位:
Safety of Hendra virus anti-G glycoprotein monoclonal antibody in humans
-
批准号:nhmrc : 1041833
-
项目类别:NHMRC Strategic Awards
-
资助金额:$26.67万
-
财政年份:2012
-
负责人:A/Pr E Geoffrey Playford
-
依托单位:
Intravascular device administration sets: Replacement after Standard Versus Prolonged use (The RSVP Trial)
-
批准号:nhmrc : 1008428
-
项目类别:Project Grants
-
资助金额:$107.44万
-
财政年份:2011
-
负责人:A/Pr E Geoffrey Playford
-
依托单位:
Predicting the risk of invasive candidiasis in critically ill patients
-
批准号:nhmrc : 512307
-
项目类别:NHMRC Project Grants
-
资助金额:$83.9万
-
财政年份:2008
-
负责人:A/Pr E Geoffrey Playford
-
依托单位:
国内基金
海外基金
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
-
批准号:81973152
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2019
-
负责人:胡东生
-
依托单位: